Innovate U.K. is a NPO that offers funding services to support science and technology innovations. The organization offers services and information on births, deaths, marriages, business, self-employed, childcare, parenting, citizenship, law, disabled persons, transportation, education, environment, housing, money, tax, travel, immigration, and jobs. Innovate U.K. is based in Swindon.
Programme Director of Industrial Strategy Challenge Fund
Will Drury
Executive Director, Digital and Technologies
Paul Gadd
Deputy Director
Dr. Tom Jenkins
Deputy Director
Scott James O'Brien
Director, Innovation Finance
Nigel Walker
Deputy Director, Lending and Investor Partnerships
Dave Wilkes
Director of Innovation Ecosystem
Past deals in Early Venture Stage
Z-PULSE
Grant in 2025
Z-PULSE, a spin-off from the University of Surrey, creates wearable health sensors that run on their own power.
TreQ
Grant in 2025
TreQ is a manufacturing company that builds and operates bespoke quantum computing clusters.
Fotenix
Grant in 2025
A diagnostics company providing deterministic monitoring to crop producers. Our sensors use deployed colours of light, combined with embedded artificial intelligence to detect plant status, such as disease. A FOTENIX enabled sprayer provides the next level of online precision farming, and our cloud platform enables agronomic insights based on the inputs used.
North AI
Grant in 2025
North AI operates as an AI start up company for media sector.
ReactWise
Grant in 2025
ReactWise offers an artificial intelligence Co-Pilot that optimizes chemical processes through a data-driven platform. This innovative solution allows users to identify ideal chemical process parameters without the need for coding. The platform features data-driven optimization and advanced data analysis capabilities, all presented through an intuitive user interface. ReactWise aims to streamline the analysis and optimization of chemical reactions, ultimately saving time and resources for users in laboratory settings. Additionally, the company provides dedicated customer support to enhance the user experience.
StimOxyGen
Grant in 2025
StimOxyGen specializes in developing innovative, pH-responsive nanoparticles designed to generate oxygen in hypoxic tumors. This technology aims to enhance the effectiveness of cancer treatments such as radiotherapy and chemotherapy by addressing tumor hypoxia, a significant clinical challenge. F
Constructive Bio
Grant in 2025
Constructive Bio is a biotechnology company focused on genome rewriting to unlock new possibilities in bioprocesses and biopharmaceuticals. The company transforms living cells into biofactories, producing sustainable materials and therapeutics. By harnessing advanced technologies, Constructive Bio creates virus-resistant organisms and biosynthesizes a range of enzymes, pharmaceuticals, and biomaterials. This innovative approach allows clients to reprogram genetic codes, enabling the creation of natural molecules that were previously inaccessible through conventional biology. Through its unique capabilities, Constructive Bio aims to lead the development of the next generation of sustainable solutions in the life sciences.
LinkGevity
Grant in 2025
LinkGevity is an drug discovery company that focuses on life span and diseases associated with aging.
Electric Sheep
Grant in 2025
Electric Sheep is dedicated to accelerating the Visual Effects (VFX) industry with cutting-edge AI technology. With a focus on speed, security, and scale, we are streamlining Film/TV workflows. The first step on our journey is rotoscoping. After years of camera to post experience for Netflix, Amazon and Disney among others, we saw an opportunity to take the challenges faced in VFX and leverage emerging AI technology to solve them. Thus Electric Sheep was born. Our mission is to allow artists to get back to what they do best - telling stories through creative, stunning and impactful visual effects.
Lant Medical
Grant in 2025
Lant Medical operates as a health tech company.
SEQUENTIAL
Grant in 2025
Sequential Skin and Sequential Bio fall under the umbrella of Sequential: The Skin Microbiome Testing Co™ Awarded the title "Most Significant" Testing Solution in the Industry - (Cosmetics & Toiletries, 2022), Sequential Bio is the skin microbiome company of the industry that specializes in microbiome testing and claims substantiation for brands formulating products for skin, scalp, vagina/vulva and oral care. Sequential offers a full end-to-end platform from study design, recruitment and testing, to analysis, and support on formulation development and certification. And it’s all done in vivo! Sequential Skin on the other hand is revolutionising skin health with the world's first consumer skin microbiome test. Formed of an award-winning team with a mission to empower individuals to make better-informed decisions about their skin health. (www.sequentialskin.com) Sequential is the product of the team's combined expertise in epigenetics, genetics, and microbiome research. Supported by Innovate UK, Enterprise SG, A*STAR, Genome Institute of Singapore, IndieBio New York, SOSV, Metaplanet, Scrum Ventures, CSB, and is a resident company of Johnson & Johnson Innovation – JLABS. Seen in Tatler, Cosmetic Designs, Tech Crunch, Genome Web, La Petite Journal, Global Wellness Summit, and Yahoo.
Circadacare
Grant in 2025
Circadacare is a health technology company focused on enhancing the quality of life for older adults through innovative solutions in care environments. The company specializes in developing integrated systems that combine lighting, sensors, and software technology to synchronize the day-night cycle for residents, thereby improving their overall well-being. By translating scientific principles into practical applications, Circadacare aims to create care home lighting services that not only benefit the residents but also support staff efficiency. The solutions provided by Circadacare are designed to operate seamlessly, requiring minimal training for staff, while delivering both care outcome improvements for older adults and cost benefits for operators of nursing homes, care villages, and dementia care centers.
Ayming
Grant in 2025
Ayming is a management consulting firm headquartered in Levallois, France, that focuses on optimizing operational performance for its clients. The company provides a range of services, including consulting on human resources costs, tax strategies, operational costs optimization, software solutions, and energy and environmental issues. Additionally, Ayming offers advisory services related to work contributions and wage audits. By leveraging these diverse consulting offerings, Ayming aims to help organizations enhance their efficiency and overall performance while effectively managing social costs associated with taxes and financial operations.
EnrichMyCare
Grant in 2025
EnrichMyCare helps to solve some of the critical problems including delays with communication and care, information sharing and disjointed healthcare provision across health, social care and education. The platform offers opportunities for automating carepathways, remotely monitoring management plans and compliance with exercise and splinting programmes. Our early research suggests that this would help with accelerating care, better patient monitoring and engagement to prevent disabilities from developing and improving the overall care experience whilst also reducing healthcare costs.
Centre for Sustainable Innovation
Grant in 2024
Centre for Sustainable Innovation focuses on addressing new and traditional sustainability challenges through innovative solutions.
Wordnerds
Grant in 2024
Wordnerds teach computers to understand language, make decisions, and find actionable insights. Using AI and advanced linguistics, they are turning the internet into the world’s biggest focus group.
MAKOR RESOURCES
Grant in 2024
Makor Resource's strategy hinges on four pillars: advancing artisanal and small-scale mineral sector development; developing human and technological capacities; building blockchain-enabled “Mine to Main Street” value chains; and promoting sustainable investment and communal stewardship.
Dia Beta Labs
Grant in 2024
DRG labs at Ulster, maintain full access to the cutting-edge facilities on-site and its connection to a group of scholars and experts in diseases. Afterward, lead molecules for animal research are identified by advancing therapeutic candidates through our discovery platform, which uses industry-standard methodologies and models.
BeamXR
Grant in 2024
BeamXR is a gaming business that develops a game-changing streaming software development kit that allows extended reality (XR) games to be live-streamed via popular streaming services.
Automated Architecture
Grant in 2024
Automated Architecture provides the technological infrastructure for a distributed robotic micro-factory network producing sustainable timber housing.
GScan
Grant in 2024
GScan is at the forefront of transforming inspection technology by utilizing muon-based scanning, which leverages natural cosmic radiation to safely and accurately analyze chemical compositions of various materials. Its flagship product, MuonFLUX, enables in-depth scanning of reinforced concrete, offering crucial insights that can prevent the collapse of vulnerable infrastructure such as bridges and buildings. The technology not only enhances the lifespan of existing structures without increasing risk but also significantly reduces maintenance costs by pinpointing critical repair areas. Additionally, GScan's solution contributes to the decarbonization of the concrete and cement industry, which is a major contributor to global CO2 emissions. In 2023, the company successfully executed its first commercial projects, generating revenue of €1.5 million. GScan's innovative approach has wide-ranging implications across various sectors, including public safety, industrial applications, and space exploration.
Keltic Pharma Therapeutics
Grant in 2024
Keltic Pharma Therapeutics enhances drug discovery through innovative scientific research, resulting in a healthier future.
mannyAI
Grant in 2024
MannyAI is a fashion technology startup that operates an artificial intelligence-powered sourcing network designed for fashion brands and factories. The company's platform enables small batch production by aggregating similar orders, which allows factories to optimize their operations and improve production efficiency. MannyAI offers features such as instant pricing and streamlined order management, helping fashion brands minimize inventory risks while enhancing their overall supply chain processes. Through its innovative approach, MannyAI aims to bridge the gap between fashion brands and manufacturers, fostering a more agile and responsive production environment in the industry.
BindEthics
Grant in 2024
BindEthics offers a sustainable, non-toxic glue not created from fossil fuels.
Nolana AI
Funding Round in 2024
Nolana is an AI product development platform enabling managers to oversee software development workflows with the support of AI agents.
Reneural Technologies
Grant in 2024
The goal of Reneural is to use technology to revolutionize healthcare delivery by increasing its effectiveness, efficiency, and accessibility for both patients and physicians.
AceOn Group
Grant in 2024
AceOn Group is pioneering energy storage and battery company.
HUID
Grant in 2024
HUID is investigating the possibilities of onion peels in an effort to lower our consumption of single-use plastics. HUID seeks to develop a range of environmentally friendly material applications by utilizing the enormous amounts of waste allium that humans produce worldwide.
Near-Life
Grant in 2024
Near-Life specializes in immersive learning content, focusing on the integration of interactive video and gaming technology for training purposes. The company has developed an online learning platform that employs a gaming approach to enhance eLearning experiences. By combining video scenarios with role-play elements, Near-Life provides users with an engaging and intuitive training method. This innovative approach allows learners to actively participate in their education, making the training process more effective and enjoyable. As pioneers in the field, Near-Life continues to advance the intersection of technology, learning, and media.
Kaydiar
Grant in 2024
Kaydiar is an innovative medical device company that specializes in offloading technology, we are committed to innovating superior products for cost-effective wound care, such as orthotic devices, bed mattresses, wheelchair cushions and prosthetic sleeves.
Caledonian Climate
Grant in 2024
Caledonian Climate operates as a peatland restoration consultancy.
BIOVIT
Grant in 2024
BIOVIT develops fortified foods using 100% organic plant extracts which are naturally high in vitamins and minerals.
Low Carbon Materials
Grant in 2024
Low Carbon Materials is a climate-tech company dedicated to creating innovative, low-carbon alternatives for traditional construction materials. By transforming post-consumer, post-industrial, and pre-manufacture waste plastic into lightweight, eco-friendly plastic aggregates, the company aims to mitigate environmental impact. These aggregates serve as sustainable substitutes for sand in conventional building materials, enhancing thermal insulation while significantly reducing carbon emissions associated with construction processes. Through its focus on sustainable practices, Low Carbon Materials contributes to the development of environmentally responsible construction solutions.
Zulu Ecosystems
Grant in 2024
Zulu Ecosystems operates an automated platform aimed at regenerating natural carbon sinks and habitats. The organization utilizes a science-based approach to evaluate, create, and structure nature-based projects. By integrating scientific methods with financial precision, Zulu Ecosystems assists landowners, investors, specialists, and businesses in developing optimal forest ecosystems and generating high-quality carbon credits. This focus on rebuilding ecosystems and enhancing carbon sequestration aligns with broader environmental goals, making it a key player in the sustainability sector.
Epitopea
Grant in 2024
Epitopea is a biotechnology company focused on developing innovative immunotherapies for cancer treatment by targeting a new class of tumor-specific antigens. The company employs a proprietary approach that combines immunopeptidomics, mass spectrometry, genomics, and bioinformatics to identify conserved, aberrantly expressed tumor-specific antigens hidden within cancer's non-coding DNA. This technology aims to create therapies that effectively eliminate malignant cells while minimizing damage to healthy tissue, thereby reducing side effects and providing lasting benefits for patients. Research conducted by Drs. Claude Perreault and Pierre Thibault at the Institute for Research in Immunology and Cancer at Université de Montréal has been instrumental in the discovery of these novel antigens, known as Cryptigen™ TSAs, which are shared among patients with the same cancer type.
Viability
Grant in 2024
Viability develops software specifically for the homebuilding industry, aimed at automating site assessments and facilitating comparisons between various construction sites. The platform emphasizes off-site building techniques, which help reduce overall construction costs, dependence on skilled labor, and project timelines. By promoting these innovative methods, Viability not only enhances the efficiency of real estate developers but also encourages sustainable practices that minimize the carbon footprint associated with new home construction. This approach allows developers to quickly evaluate and maximize their opportunities while addressing the challenges of sustainable building.
Marketing Engine
Grant in 2024
Marketing Engine is a marketing tool which helps marketers to build and share a marketing plan - and overlay results in real-time.
PuriFire Energy
Grant in 2024
Transforming Waste Water and wet feedstocks into Green Methanol and other sustainable fuels
Theolytics
Grant in 2024
Theolytics Limited is a clinical-stage biotechnology company founded in 2017 and based in Oxford, United Kingdom. The company specializes in developing oncolytic viral therapies to combat cancer, utilizing a phenotypic screening platform that facilitates the discovery and development of effective, targeted treatment candidates. These therapies are designed for intravenous delivery and tailored to specific patient populations, aiming to provide innovative care options. In addition to advancing its internal pipeline of programs that address both solid and liquid tumors, Theolytics is also focused on forming strategic partnerships to enhance and expedite its pipeline development.
Naitive
Grant in 2024
Naitive is a population health company focused on improving patient care through AI-enabled clinical pathways and medical device technology. The company develops software that employs artificial intelligence, clinical data, and digital interventions to enhance the identification, treatment, and coordination of care for chronic diseases. By leveraging advanced computational capabilities, Naitive aims to support clinicians in transforming patient care while simultaneously reducing costs, time, and the failure rates commonly associated with chronic disease management.
Siloton
Grant in 2024
Siloton is a medical device manufacturer focused on creating diagnostic imaging devices for ophthalmology. The company specializes in developing advanced portable optical coherence tomography devices designed to address challenges in eye care. Their hand-held sub-surface imaging technology allows for home-based scanning, providing users with the ability to monitor their eye health and contribute to the prevention of avoidable blindness.
BoobyBiome
Grant in 2024
BoobyBiome is a company focused on improving infant health through microbiome research. It specializes in developing probiotic supplements specifically designed for infants with compromised microbiomes, particularly those born prematurely. By recreating the beneficial bacteria associated with breast milk, BoobyBiome aims to support healthy infant development. The company is also working on formula milk probiotics to create a substitute that closely resembles breast milk, allowing infants to receive the essential bacteria that contribute to their gut health and immune system.
TwinLabs.ai
Grant in 2024
Through easy-to-use Digital Twins, TwinLabs.ai enables venue and event operators to reduce their costs, increase sustainability, improve safety and generate new revenue streams using the very latest AI, IoT, 3D graphics and Digital Twin technologies.
Awen Oncology
Grant in 2024
Awen Oncology is a pharmaceuticals start-up that is drugging developmentally-silent oncogenic drivers.
Purple Transform
Grant in 2024
Purple Transform operates as an artificial intelligence company. Purple Transform improves decision accuracy with digital intelligence.
OW Smell Made Digital
Grant in 2024
OW Smell Made Digital specializes in developing innovative software and hardware solutions aimed at controlling and enhancing the experience of smell. The company focuses on digital smell technology that explores the potential of fragrances to augment various content, services, or products. By integrating robust algorithms and a comprehensive database, OW Smell Made Digital enables customers to identify specific smells and their perceptual effects. This technology allows for seamless integration with third-party tools, providing users with complete digital control over scent experiences. The company's offerings are designed to enhance user engagement and create immersive sensory experiences.
Monumo
Grant in 2024
Monumo is a deeptech engineering company specializing in the development of advanced electric motors. By integrating simulation, machine learning, and artificial intelligence with innovative motor design, Monumo aims to create next-generation electric vehicle motor systems that exceed traditional human capabilities. The company focuses on enhancing the efficiency of energy use globally through its cutting-edge electromagnetic engineering tools. These tools are designed to optimize electric motors to their fundamental limits, leveraging a blend of advanced electronic and mechanical engineering expertise alongside the latest technological advancements. Monumo's efforts contribute to the establishment of a more sustainable future.
Medannex
Grant in 2024
MedAnnex Limited is a biotechnology company based in Edinburgh, United Kingdom, focused on developing innovative treatments for patients suffering from autoimmune diseases and cancers. Established in 2009, the company specializes in creating monoclonal antibodies, particularly annexuzlimab, which targets and inhibits annexin-A1. This therapeutic approach aims to modulate both the innate and adaptive immune systems, enhancing treatment options for physicians and improving patient outcomes. MedAnnex is committed to advancing first-in-class antibody therapies that can significantly benefit individuals affected by these challenging health conditions.
Cumulus Neuroscience
Grant in 2024
Cumulus Neuroscience develops an AI-based digital biomarker platform to aid in the resolution of the most pressing healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience's platform is intended to provide the critical data and insight required for more rapid, robust, and cost-effective clinical trials that improve patient access to new therapies. The platform's novel insights change the future of clinical trials in brain disorders, allowing life-changing therapies to reach patients faster and more affordably.
ThirtyFiveBio
Grant in 2024
ThirtyFiveBio is a biotechnology agency focused on developing innovative protein modulators aimed at treating severe gastrointestinal diseases, which represent a significant unmet clinical need. The company specializes in genetically and pharmacologically validated modulators that facilitate a comprehensive drug discovery program. This program is designed to identify small-molecule modulators of specific proteins, with the potential to impact a wide range of digestive system malignancies. By targeting GPR35 signaling, ThirtyFiveBio's approach aims to provide therapeutic options that may help in preventing tumor growth associated with gastrointestinal cancers.
Marine Power Systems
Grant in 2024
Marine Power Systems Ltd. is a marine renewables technology development company based in Swansea, United Kingdom, established in 2008 by engineering graduates from Swansea University, Dr. Gareth Stockman and Dr. Graham Foster. The company focuses on the development and commercialization of innovative wave energy converters, including its flagship product, WaveSub, along with DualSub and WindSub devices. These converters operate under the sea's surface, adjusting their depth to optimize energy extraction and minimizing damage during severe weather conditions. By harnessing wave energy, Marine Power Systems aims to reduce the costs associated with energy generation from ocean waves, contributing to the renewable energy sector and promoting sustainable energy solutions.
Vector Photonics
Grant in 2024
Vector Photonics is a spin-out company from the University of Glasgow, located in Glasgow, Scotland, a notable center for optical and photonics innovation. The company specializes in developing advanced semiconductor laser technology aimed at enhancing data communications and additive manufacturing processes, including metal and plastic printing. Its innovative approach centers on photonic crystal surface-emitting lasers, which are cost-effective and emit light from their top surface, similar to vertical-cavity surface-emitting lasers (VCSELs). This design facilitates easy packaging and integration into printed circuit boards (PCBs) and electronic assemblies, allowing various industries to seamlessly adopt this semiconductor laser technology into their operations.
Nuclera
Grant in 2024
Nuclera specializes in providing a protein prototyping system designed to enhance drug discovery by making proteins readily accessible to researchers. The company's eProtein Discovery system enables scientists to quickly produce and evaluate proteins, thus accelerating their research efforts. Nuclera's automated platform delivers reliable, high-quality, and soluble proteins within a specified timeframe, facilitating the scale-up of protein projects. The integration of technology, including cell-free protein synthesis and digital microfluidics on smart cartridges, allows for efficient, high-throughput access to proteins. This streamlined approach supports researchers in advancing their protein projects more rapidly and effectively.
AgriSound
Grant in 2024
AgriSound is an agri-tech company that specializes in advanced sound analysis for monitoring insect activity, particularly focusing on pollinators. The company has developed a pollination management platform that utilizes sound, environmental, and vision technology sensors to monitor and predict pollinator behavior across agricultural estates. This platform enables users, including beekeepers, farmers, and researchers, to assess hive status in near real-time through the use of predictive algorithms. By providing insights into insect activity and environmental changes affecting pollination, AgriSound's technology allows for remote management of beehives and supports timely decision-making. This innovation aims to enhance agricultural operations and promote biodiversity by suggesting appropriate actions to maintain optimal pollination conditions.
KYMIRA
Grant in 2024
KYMIRA is an e-commerce company specializing in smart garments and textiles designed to enhance athletic performance and overall well-being. The company develops innovative products that utilize compression fabric combined with infrared and sensor technology. These garments harness and recycle the energy generated by athletes, aiming to improve performance, address chronic health issues, reduce injury risks, and enhance sleep quality. Additionally, KYMIRA's products provide valuable data insights for both men and women, enabling sports enthusiasts to optimize their training and recovery processes.
LIfT BioSciences
Grant in 2024
LIfT BioSciences is a biotechnology company based in London, England, founded in 2016. The company specializes in a novel allogeneic innate immuno-cell therapy platform known as Neutrophil Only Leukocyte Infusion Therapy (N-LIfT). This platform enables the large-scale production of Immunomodulatory Alpha Neutrophils (IMANs) derived from induced pluripotent stem cells (iPSCs) for various therapeutic applications. LIfT BioSciences focuses on developing CAR neutrophil cell therapies that address the limitations of existing treatments for solid tumors. These therapies work by directly attacking tumors and indirectly enhancing the immune response, effectively transforming the tumor microenvironment to recruit additional immune cells for a more robust and lasting attack on the cancer. By employing proprietary enhancement media and genetic engineering, LIfT BioSciences aims to significantly increase the cancer-fighting capabilities of these engineered cells, potentially providing patients with greatly improved therapeutic outcomes.
Stratiphy
Grant in 2024
Stratiphy is an investment application that leverages Robo-advisory technology to assist the next generation of investors in making informed investment decisions aligned with their values and sustainability objectives. The platform offers personalized investment strategies by analyzing historical performance and comparing various scenarios and investment options through advanced analytics. By integrating sustainability and ESG data, Stratiphy simplifies the process of tracking sustainable investments, allowing users to invest in a manner that reflects their ethical and environmental priorities while also aiming to make a meaningful impact.
University of Bristol
Grant in 2024
The University of Bristol is a red brick research university that offers a range of educational courses and services. The university is organized into six academic facilities: Faculty of Arts, Faculty of Engineering, Faculty of Medical and Veterinary Sciences, Faculty of Science, Faculty of Medicine and Dentistry, and Faculty of Social Sciences and Law. These faculties together award a range of academic degrees spanning bachelor's and master's degrees as well as junior doctorates and higher doctorates. University of Bristol was established in 1876 and is based in Bristol, United Kingdom.
Nami Surgical
Grant in 2024
Nami Surgical provides robotic surgery technology solutions to enhance patient care while giving surgeons intuitive, high-performance moveable instruments.
Signapse
Grant in 2024
We are developing real-time sign language translator software. We are a team of Deaf and hearing people; entrepreneurs, engineers, and researchers. We build artificial intelligence solutions for clients who want access to sign language translation and interpretation. Broadcast media, announcements in public spaces, and websites can be inaccessible if you are a sign language user and it is our job to make sure your organisation provides great access for Deaf people.
Carbonbit Technologies
Grant in 2024
Carbonbit Technologies provides sustainable solutions focused on carbon reduction, energy efficiency, and environmental impact management.
enee.io
Grant in 2024
enee.io specializes in designing and developing battery monitoring systems that enhance the efficiency and longevity of energy systems, particularly in renewable power applications. By providing users and suppliers of renewable energy with critical insights, the company aims to optimize energy usage and improve the overall health of energy systems. This technology is especially beneficial for individuals and businesses in areas with unreliable grid access, as it enables them to operate more effectively and maintain backup power supplies. Overall, enee.io's solutions contribute to making reliable and affordable energy more accessible, thereby increasing profitability for users in the renewable energy sector.
MedicSen
Grant in 2024
MedicSen is a start-up dedicated to health care, to technological innovation as a key tool. With several projects under mind, we have launched the most ambitious of them all, GlycSen. It is designed for intelligent treatment of insulin dependent diabetes device.
SleepCogni
Grant in 2024
SleepCogni is focused on developing innovative sleep aid technology that facilitates a personalized wind-down process to enhance sleep quality. The company's device, activated manually, utilizes sensors worn on the user's index finger to monitor key physiological and behavioral indicators, including heart rate, mental alertness, skin temperature, and movement. By employing cognitive behavioral therapy through biofeedback—delivered via visual, auditory, and tactile cues—SleepCogni aims to help users relearn healthy sleep patterns. This approach is designed to assist individuals in overcoming insomnia and improving their overall sleep cycle, offering a tailored solution to address common sleep challenges.
AudioStrip
Grant in 2024
AudioStrip operates as a tool used by musicians to split vocals from backing music in audio files.
Monument Therapeutics
Grant in 2024
Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
Qumulus
Grant in 2024
Qumulus is all about making cloud services easier and more affordable. We offer a subscription-based private cloud platform that's perfect for SMEs and developers. Our setup combines OpenStack with the best bare-metal servers and open-source tools out there, giving you a super user-friendly experience. Plus, our fixed-cost, no-nonsense approach means you get top-notch cloud services without the usual hefty price tag or complexity.
GaitQ
Grant in 2024
GaitQ Limited, founded in 2019 and based in Oxfordshire, United Kingdom, specializes in developing a medical device aimed at assisting individuals with Parkinson's disease in overcoming freezing of gait. The company's product, known as the GaitThaw device, is small and portable, designed to utilize clinically proven sensory cues. These cues facilitate the re-establishment of the connection between the brain and the body, enabling patients to walk more smoothly and confidently.
BSF Enterprise
Grant in 2024
BSF Enterprise is focused on advancing biotechnology solutions through a strategic approach of acquiring businesses within the biotech, marketing, and e-commerce sectors. The company specializes in cell-based tissue engineering, which enables the development of lab-grown products such as cultured meat, lab-grown leather, human corneas, collagen, and skin substitutes. By leveraging these innovative technologies, BSF Enterprise aims to facilitate sustainable solutions across multiple industries, contributing to significant advancements in the field of biotechnology.
Graphene Trace
Grant in 2024
Graphene Trace is a company to help wheelchair users and hospitals prevent against pressure ulcers.
Outfield
Grant in 2024
Outfield is an agritech company focused on transforming orchard management through its precision farming platform. By utilizing unmanned drones and advanced image recognition technology, Outfield collects and analyzes data to deliver actionable insights on key aspects such as fruit counts, blossom mapping, crop load management, and yield forecasting. This innovative approach significantly improves the accuracy of yield estimates, reducing common errors from 20% to less than 10%, thereby enhancing productivity and profitability for growers. The platform processes drone-captured images and returns detailed maps and insights to users within 24 hours, allowing for efficient decision-making. Currently, the service is being tested by growers in the UK, New Zealand, and South Africa, who have praised its flexibility and speed. Outfield aims to scale its operations, expand its offerings, and enter new market segments as it addresses the growing demand for sustainable and efficient fruit farming solutions.
TRUSS
Grant in 2024
Instant access to rich, actionable data about fashion products to power resale.
Loughborough University
Grant in 2024
Loughborough is a fantastic place to study and work, boasting unrivalled sporting achievement, internationally acclaimed research and outstanding teaching quality. Our attractive single-site campus provides an environment that is stimulating and supportive, offering first-rate facilities for both students and staff. There is a real pride in the University that touches everyone associated with it.
Cumulus Neuroscience
Grant in 2024
Cumulus Neuroscience develops an AI-based digital biomarker platform to aid in the resolution of the most pressing healthcare challenges in neurodegeneration and psychiatry. Cumulus Neuroscience's platform is intended to provide the critical data and insight required for more rapid, robust, and cost-effective clinical trials that improve patient access to new therapies. The platform's novel insights change the future of clinical trials in brain disorders, allowing life-changing therapies to reach patients faster and more affordably.
Presymptom Health
Grant in 2024
Presymptom Health develops a portfolio of clinical decision support algorithms and blood tests to enable early intervention and transform critical care outcomes.
Bizumi
Grant in 2024
Bizumi specialises in personalised, sustainable business travel, delivered by its end-to-end travel management platform. Our vision is to be the world’s leading personalised business travel management company prioritising and satisfying the needs of the traveller, and empowering organisations to achieve sustainability goals through intelligent, informed decision making.
NuKoKo
Grant in 2024
NuKoKo is a bean-to-bar manufacturing company specializing in cocoa-free chocolate. By utilizing ingredients sourced from the UK, the company has developed a patent-pending technology that allows for the production of a novel type of chocolate. This innovative product is designed to be healthier and has a significantly reduced environmental impact compared to traditional chocolate production methods. NuKoKo's offerings are characterized by low carbon emissions, low sugar content, and high protein, catering to consumers seeking sustainable and nutritious alternatives in the chocolate market.
IXICO
Grant in 2024
IXICO is a UK-based company specializing in clinical trial services and technology focused on imaging endpoints for the pharmaceutical and biotechnology sectors. The company primarily operates in the fields of oncology and neurology, offering end-to-end imaging services that cater to various therapeutic areas, including Alzheimer's, Parkinson's, Huntington's disease, and other neurodegenerative conditions. IXICO supports clients throughout the entire clinical research journey, providing services for early and late-phase clinical development, post-marketing assessments, and consultancy. With a presence in multiple countries, including the United States, Switzerland, the Netherlands, and Ireland, IXICO collaborates with pharmaceutical companies, academia, and medical charities to advance the treatment of complex diseases.
University of Nottingham
Grant in 2024
The University of Nottingham is a prominent institution known for its comprehensive and research-led approach to education. It operates an international business school with campuses in the UK, China, and Malaysia, emphasizing strong ties to the corporate sector and delivering high-quality teaching programs. The business school is recognized for its influential research, particularly in areas such as banking and finance, entrepreneurship, innovation, and business sustainability. The university is financially secure and committed to enhancing the international experience for its students, preparing them for diverse intellectual, professional, and personal endeavors. Additionally, the University manages an endowment fund that supports scholarships, academic positions, and various research and public service initiatives.
Cortirio
Grant in 2024
Cortirio specializes in the development of portable brain imaging technology aimed at diagnosing and monitoring traumatic brain injuries, which are a leading cause of death and disability among individuals under 40. The company's innovative portable scanners utilize near-infrared imaging with enhanced spatial resolution to deliver point-of-care medical imaging. This technology enables healthcare providers to access vital information throughout the clinical pathway, facilitating automatic analysis and data transfer. By providing timely and accurate diagnostic capabilities, Cortirio's devices empower clinicians to make quicker decisions, ultimately improving care for patients suffering from brain injuries and strokes.
SolasCure
Grant in 2024
SolasCure Limited is a biotechnology company based in Wales, United Kingdom, focused on developing innovative solutions for patients with chronic wounds. Founded in 2017, the company is advancing its product Aurase, a hydrogel designed to facilitate wound debridement by removing dead, damaged, or infected tissue to enhance healing. Aurase incorporates a recombinant enzyme derived from maggots, leveraging biomimicry and evidence-based medicine to improve wound care outcomes. SolasCure aims to provide effective wound bed preparation across various healthcare settings, ultimately accelerating the healing process for individuals suffering from chronic wounds.
Occuity
Grant in 2024
Occuity Ltd is a company based in Reading, United Kingdom, that focuses on the research, design, and manufacture of non-contact optical instruments for healthcare diagnostics and monitoring. Founded in 2019, it offers a range of handheld devices, including pachymeters, pupillometers, and keratometers, which are utilized in both human and veterinary optometry. These instruments employ light to analyze the eye, facilitating direct measurements that assist optometrists and ophthalmologists in diagnosing and monitoring various health conditions, such as diabetes and Alzheimer's disease. By providing innovative non-contact solutions, Occuity aims to enhance the effectiveness and accessibility of diagnostic and screening technologies in the healthcare sector.
CarbonLaces
Grant in 2024
CarbonLaces is the open marketplace for climate finance, bridging the supply and demand for capital gaps through real data, tools, and financing. They are scaling up the built environment to decarbonise faster while making the financing work in net new ways.
University of Birmingham Endowment
Grant in 2024
The University of Birmingham Endowment is an integral part of the University of Birmingham, based in the United Kingdom. This endowment supports a variety of academic initiatives, including scholarships, professorships, and research programs, which contribute to the university's mission of fostering innovation and advancing knowledge. With a long-standing tradition of excellence, the University of Birmingham is committed to pushing the boundaries of research and education, leveraging its expertise to address contemporary challenges. The endowment's earnings play a crucial role in enabling the university to maintain its reputation for impactful research and academic excellence, ensuring that it continues to develop great minds and influence lives both locally and internationally. The management of the endowment assets is overseen by the council members, who are dedicated to maximizing the fund's contributions to the university's objectives.
North AI
Grant in 2024
North AI operates as an AI start up company for media sector.
Riverlane
Grant in 2024
Riverlane is a business focused on developing quantum computing software and engineering instruments to enhance the performance of quantum computers. The company collaborates with quantum computer manufacturers to create essential hardware and software tools that address the challenges posed by unstable qubits and system defects. By designing an ultra-low latency quantum operating system, Riverlane accelerates quantum-classical hybrid algorithms, thereby advancing hardware research and development. Their algorithms are specifically engineered to optimize the utilization of the complete quantum computing stack, helping hardware partners mitigate the system errors that currently hinder the effectiveness of quantum computers. Through these innovative solutions, Riverlane aims to transform experimental quantum technologies into viable commercial products.
Recap
Grant in 2024
Recap operates a cryptocurrency accounting platform designed to simplify tax compliance and portfolio management for users engaged in cryptocurrency transactions. The platform connects with users' accounts across various wallets, blockchains, and exchanges to facilitate portfolio tracking and tax calculation. By offering features such as end-to-end encryption and tax reporting tailored for the US and UK, Recap enables clients to gain clear insights into their cryptocurrency investments and optimize their tax positions. The user-friendly and privacy-focused app addresses the complexities of managing numerous transactions, making it easier for individuals to navigate the intricacies of crypto taxes.
Sprint Electric
Grant in 2024
Sprint Electric produces digital motor control solutions. Their product includes pl/x series, jl/x series, pl/xd series, open chassis-mount dc drives, and ancillary items. They offer customer support through email and phone contact.
IVY TECH LTD
Grant in 2024
IVY TECH Ltd is a multidisciplinary research and innovation company focusing on pushing the boundaries by enabling the technologies to make the fourth-industrial revolution a reality. Vison – Empowering and revolutionising organisations to be the global leaders in engineering and technology. Mission - Assisting organisations by providing cutting-edge solutions to compete in the global market.
IVY TECH LTD
Grant in 2024
IVY TECH Ltd is a multidisciplinary research and innovation company focusing on pushing the boundaries by enabling the technologies to make the fourth-industrial revolution a reality. Vison – Empowering and revolutionising organisations to be the global leaders in engineering and technology. Mission - Assisting organisations by providing cutting-edge solutions to compete in the global market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.